Navigation Links
Merrimack Pharmaceuticals' Phase 1 Research Supports MM-121 Potential For Investigation As Combination With Chemotherapy In Patients With Advanced Solid Tumors
Date:6/4/2013

.pdf">website.  

About Merrimack Pharmaceuticals, Inc.
Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies its systems biology-based approach to biomedical research throughout the research and development process. Merrimack currently has six oncology therapeutics in clinical development.

Forward-Looking Statement
To the extent that statements contained in this press release are not descriptions of historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements include any statements about Merrimack's strategy, future operations, future financial position and future expectations and plans and prospects for Merrimack, and any other statements containing the words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions. In this press release, Merrimack's forward-looking statements include statements about the potential effectiveness of its drug candidates in new indications and its ability to translate clinical data into future clinical success. Such forward-looking statements involve substantial risks and uncertainties that could cause Merrimack's clinical development programs, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in the initiation of future clinical trials, availability of data from ongoing clinical trials, expectations for regulatory approvals and other matters that could affect the availability
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Merrimack Pharmaceuticals Preclinical Research Shows MM-111 Restores Sensitivity To Chemotherapy And HER2-targeted Treatment In Gastric Cancer Model
2. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
3. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
4. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
5. Isis Pharmaceuticals Reports Encouraging Data on ISIS-STAT3rx in Patients With Cancer
6. Ferring Pharmaceuticals Inc. Announces $1M Donation to the Alliance for Fertility Preservation, a Newly Formed Charitable Organization
7. Ampio Pharmaceuticals Provides Clinical Updates
8. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
9. Auxilium Pharmaceuticals, Inc. To Present At The Jefferies 2013 Healthcare Conference
10. Isis Pharmaceuticals Announces Exercise of Underwriters Option to Purchase Additional Shares
11. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Alemania, December 17, 2014 ... anterior, con un alto nivel de gasto en investigación ... fiscal 2013/14 (finalizado el 30 de septiembre de 2014) ... a 4.287 millones de euros (año anterior: 4.190 millones ... moneda desfavorables. Las ganancias (EBIT) crecieron un 14 por ...
(Date:12/17/2014)... 2014  Strategic Health Services, Inc. (SHS), a leading ... a strategic agreement with QualCare, Inc., a leading provider of ... regional marketplace.  This agreement will further QualCare,s population ... solutions QualCare brings to its clients in ... QualCare plans cover more than 800,000 member ...
(Date:12/17/2014)... YORK , Dec. 17, 2014 ... imaging (MRI), the MRI market is seeing new ... and breast MRI scans account for the majority ... a higher resolution of images, which are creating opportunities ... imaging (MRI) market is growing at a rate ...
Breaking Medicine Technology:ZEISS confirma su posición en un entorno difícil 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3
... Ferring Pharmaceuticals presented an interim study analysis indicating that ... in vitro fertilization (IVF) cycles using a gonadotropin-releasing ... poster at the 65th Annual Meeting of the American ... 2009. , MENOPUR® vs. rFSH in ...
... NANJING, China, Oct. 20 /PRNewswire-Asia/ -- ... the "Company"), a leading pharmaceutical company,specializing in development, ... in China, today announced an agreement with,OSI Pharmaceuticals, ... OSI-930 in China. , ...
Cached Medicine Technology:Research Compares MENOPUR(R) With rFSH in GnRH Antagonist IVF Cycles 2Research Compares MENOPUR(R) With rFSH in GnRH Antagonist IVF Cycles 3Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 2Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 3
(Date:12/20/2014)... Columbus, OH (PRWEB) December 20, 2014 ... contend they suffered uncontrollable bleeding and other ... District Court, Eastern District of Louisiana for coordinated pretrial ... Panel on Multidistrict Litigation (JPML) issued an order Friday ... tag-along actions pending in 22 federal courts to the ...
(Date:12/19/2014)... It’s very easy to become overwhelmed with the ... to the wayside until Christmas and the New Year are ... and that burning desire to just escape it all and ... to Telluride with a no-fuss, affordable package. Montrose Days Inn ... resort, and ensure that all accommodations are met. Plus, everyone ...
(Date:12/19/2014)... Branson, Missouri (PRWEB) December 19, 2014 ... a new official world record -- for the first time ... most prestigious record book, Guinness World Records 2015, listing the ... Steepest Wooden Roller Coaster. In additional awards announced this week, ... to See Christmas Lights in the US,” USA Today’s 10Best ...
(Date:12/19/2014)... The Medspa at Hendrick in Abilene, TX ... cosmetic brand Juvéderm. Voluma XC treats volume loss in ... at Hendrick is pleased to be able to offer ... its clients. , Voluma is the first and only ... the mid-face and cheek area. This non-invasive treatment targets ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- Potentially illness-causing E. coli ... at farmers markets, according to a new study. ... vendors from 13 farmers markets in Los Angeles and ... Out of almost 150 samples tested, 24 percent were ... salmonella, according to the researchers. Both types of ...
Breaking Medicine News(10 mins):Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 2Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 3Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 4Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:E. Coli Germs Found on Farmers Market Herbs 2
... too closely to pacemakers, ICDs , , SUNDAY, Nov. 9 ... into your coat pocket might not be exactly heart-stopping, ... your implanted cardiac device. , Harvard researchers ... sessions, in New Orleans, report that magnets in these ...
... The NHS Human,Services Foundation held its fifth annual Leading ... Regency Penn,s Landing in Philadelphia. This event is,one of ... mission,of NHS Human Services, one of the largest providers ... year the Foundation presents the Leading the Way Award ...
... The 2008 Joint Meeting of the American Academy of ... the largest and most comprehensive ophthalmic educational meeting in ... to 11 at the Georgia World Congress Center, Atlanta. ... "Breakfast with the Experts" roundtables, 95 skills transfer courses, ...
... Surgery Patients can Better Understand Their Condition at CataractSurgery.com , ... ... surgery patients and their caregivers now have a new online educational ... Cataracts affect nearly 20 million Americans age 60 and ...
... uric acid in dog breed , , FRIDAY, Nov. 7 (HealthDay ... of uric acid that lead to bladder stones in Dalmatians ... may provide clues about kidney stones in humans. , Among ... of uric acid in their urine and blood. Other dog ...
... treating colorectal cancer varies widely, with newer, life-extending therapies ... older agents, according to a study led by a ... , "The total cost of chemotherapy to treat colorectal ... patient, depending on the regimen," said Gary Lyman, M.D., ...
Cached Medicine News:Health News:MP3 Player Headphones May Throw Off Cardiac Devices 2Health News:MP3 Player Headphones May Throw Off Cardiac Devices 3Health News:Gala Raises Funds for NHS Human Services 2Health News:AAO-SOE Joint Meeting research highlights 2Health News:AAO-SOE Joint Meeting research highlights 3Health News:AAO-SOE Joint Meeting research highlights 4Health News:Alcon Sponsors Online Educational Initiative for Patients Considering Cataract Surgery 2Health News:Gene Mutation in Dalmatians Sheds Light on Kidney Stones in Humans 2Health News:Cost of treating colorectal cancer can vary by thousands per patient 2
... double lumen tube made of silicone rubber with ... to the characteristics of silicone rubber, Silbronco is ... insertion. Furthermore, the tube will not soften like ... term surgery., ,Silbronco is also especially useful ...
The Pedia-Trake® is designed to reduce the possibility of over penetration., ,Pedia-Trake® is used to establish an emergency airway in pediatric patients more than one year old....
Used for emergency airway access when endotracheal intubation cannot be performed. Supplied sterile in peel-open packages. Intended for one-time use....
Used for emergency airway access when conventional endotracheal intubation cannot be performed. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: